Dr. Tathagata Dasgupta, PhD

Dr. Tathagata Dasgupta is the Co-founder, President, and Chief Technology Officer of 4D Path. He holds a Ph.D. in String Theory from the University of Cambridge, where he was a Ramanujan Scholar and completed Part III of the Mathematical Tripos with Distinction as a member of Trinity College.

Dr. Dasgupta’s work lies at the intersection of statistical physics, machine learning, and digital pathology. His pioneering efforts led to the development of 4D Path’s patented QPOR™ platform, which applies statistical physics and principles of ergodic dynamics to decode tumor behavior and predict treatment response from standard biopsy images.

Prior to founding 4D Path, Dr. Dasgupta spent nearly a decade at Harvard University conducting interdisciplinary research in systems biology and translational oncology. There, he led collaborative programs with clinicians to integrate patient data into novel computational frameworks, advancing the use of predictive modeling in cancer research. His current focus is on bringing explainable, physics-informed AI technologies into clinical practice to improve patient outcomes across oncology.

His scholarly work spans a wide range of disciplines—from string theory and systems biology to machine learning and the quantitative study of complex human systems—reflecting a deep commitment to bridging theory and application. Dr. Dasgupta also serves on the board of an international foundation and has been a member of several prestigious national and global scientific societies.